UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Biopharma stocks listed in H1 perform poorer than non-pharma peers
by Nam Doo-hyun
2018-07-03 15:08
‘Government support for dementia tests might be ill-timed’
by Nam Doo-hyun
2018-07-03 11:47
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
by Nam Doo-hyun
2018-07-02 16:47
BMS Korea wins fight for Eliquis patent
by Nam Doo-hyun
2018-06-29 14:41
Prognostic marker for childhood obesity complications wins patent
by Nam Doo-hyun
2018-06-27 12:19
라인
Antarctic sea microorganisms; a solution to blood shortage?
by Nam Doo-hyun
2018-06-26 14:44
Korea’s drug exports to US, Europe on the rise
by Nam Doo-hyun
2018-06-25 16:09
Chong Kun Dang topped in H1 clinical trial
by Nam Doo-hyun
2018-06-21 11:11
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit
by Nam Doo-hyun
2018-06-19 11:43
‘Medytox botulinum toxin worth 600 billion won in China’
by Nam Doo-hyun
2018-06-19 09:26
라인
Will SGLT-2 inhibitors win more antidiabetic prescriptions?
by Nam Doo-hyun
2018-06-15 11:58
Highlights of US cancer meet: immunotherapy, gastrointestinal cancer
by Nam Doo-hyun
2018-06-14 15:51
Dongkook, Chong Kun Dang most popular in functional foods
by Nam Doo-hyun
2018-06-12 11:19
Drugmakers unveil new clinical data at US cancer meet
by Nam Doo-hyun
2018-06-08 14:41
Gilead successfully switches HIV drug to Genvoya
by Nam Doo-hyun
2018-06-07 15:11
라인
‘Tug-of-war in Lipiodol pricing only hurts patients’
by Nam Doo-hyun
2018-06-05 15:23
‘Baxter’s Theranova dialyzer better than conventional devices’
by Nam Doo-hyun
2018-05-30 14:29
Korea to review cost-effectiveness of PCV of Pfizer, GSK
by Nam Doo-hyun
2018-05-25 15:59
Korea exported drugs to Europe the most in first 4 months
by Nam Doo-hyun
2018-05-24 15:31
Reyon’s suit against ViroMed dismissed over VM202 rights
by Nam Doo-hyun
2018-05-24 11:38
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top